“Evaluation of the age-related eye disease study clinical lens grading system AREDS report No. 31.”, Ophthalmology, vol. 117, no. 11, pp. 2112-9.e3, 2010.
, “Dietary compound score and risk of age-related macular degeneration in the age-related eye disease study.”, Ophthalmology, vol. 116, no. 5, pp. 939-46, 2009.
, “Effect of ruboxistaurin on the visual acuity decline associated with long-standing diabetic macular edema.”, Invest Ophthalmol Vis Sci, vol. 50, no. 1, pp. 1-4, 2009.
, “Effects of multivitamin/mineral supplementation on plasma levels of nutrients. Report No. 4 of the Italian-American clinical trial of nutritional supplements and age-related cataract.”, Ann Ist Super Sanita, vol. 45, no. 2, pp. 119-27, 2009.
, “Risk of advanced age-related macular degeneration after cataract surgery in the Age-Related Eye Disease Study: AREDS report 25.”, Ophthalmology, vol. 116, no. 2, pp. 297-303, 2009.
, “A randomized, double-masked, placebo-controlled clinical trial of multivitamin supplementation for age-related lens opacities. Clinical trial of nutritional supplements and age-related cataract report no. 3.”, Ophthalmology, vol. 115, no. 4, pp. 599-607.e1, 2008.
, “The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23.”, Arch Ophthalmol, vol. 126, no. 9, pp. 1274-9, 2008.
, “Association between dietary glycemic index and age-related macular degeneration in nondiabetic participants in the Age-Related Eye Disease Study.”, Am J Clin Nutr, vol. 86, no. 1, pp. 180-8, 2007.
, “Dietary carbohydrate and the progression of age-related macular degeneration: a prospective study from the Age-Related Eye Disease Study.”, Am J Clin Nutr, vol. 86, no. 4, pp. 1210-8, 2007.
, “The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22.”, Arch Ophthalmol, vol. 125, no. 9, pp. 1225-32, 2007.
, “The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20.”, Arch Ophthalmol, vol. 125, no. 5, pp. 671-9, 2007.
, “Centrum use and progression of age-related cataract in the Age-Related Eye Disease Study: a propensity score approach. AREDS report No. 21.”, Ophthalmology, vol. 113, no. 8, pp. 1264-70, 2006.
, “C-reactive protein and homocysteine are associated with dietary and behavioral risk factors for age-related macular degeneration.”, Nutrition, vol. 22, no. 4, pp. 441-3, 2006.
, “Dietary carbohydrate intake and glycemic index in relation to cortical and nuclear lens opacities in the Age-Related Eye Disease Study.”, Am J Clin Nutr, vol. 83, no. 5, pp. 1177-84, 2006.
, “Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy.”, Ophthalmology, vol. 113, no. 12, pp. 2221-30, 2006.
, “Evaluation of plasma homocysteine and risk of age-related macular degeneration.”, Am J Ophthalmol, vol. 141, no. 1, pp. 201-3, 2006.
, “The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17.”, Arch Ophthalmol, vol. 123, no. 11, pp. 1484-98, 2005.
, “Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19.”, Ophthalmology, vol. 112, no. 4, pp. 533-9, 2005.
, “A simplified severity scale for age-related macular degeneration: AREDS Report No. 18.”, Arch Ophthalmol, vol. 123, no. 11, pp. 1570-4, 2005.
, “Age-related macular degeneration and nutritional supplementation.”, Ophthalmic Physiol Opt, vol. 24, no. 1, p. 61; author reply 61, 2004.
, “Association between C-reactive protein and age-related macular degeneration.”, JAMA, vol. 291, no. 6, pp. 704-10, 2004.
, “Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11.”, Arch Ophthalmol, vol. 121, no. 11, pp. 1621-4, 2003.
,